Maximizing Streamlining Capability of the 505(b)(2) Approach with Expert Guidance | Allucent

505(b)(2) Regulatory Pathway – Clinical Pharmacology Services

505(b)(2) Regulatory Pathway – Clinical Pharmacology Services

Understanding how to link the two products best is an essential step in maximizing the full streamlining capability of the 505(b)(2) approach and requires experts in these techniques to be successful. Allucent can help with your program’s505(b)(2) strategy by helping create the strongest PK (and sometimes PK/PD) modeling and development plans needed for your 505(b)(2)program.

Download the full case study below to learn more.

Request a Proposal

Allucent is committed to protecting and respecting your privacy. By submitting your information to us via this website your business details will be added to our database. For information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Notice. For general information on how Allucent processes personal data, please see our Privacy Policy.

Featured Content

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Join the A-Team

Want to help small and mid-sized biotech companies change the therapeutic landscape?

Subscribe to our monthly newsletter